Khemika K. Sudnawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Khemika K. Sudnawa has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Sean Calamia
Department of Pediatrics, Columbia University, New York, NY
3 shared publications- Wendy K. Chung
Department of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, USA
3 shared publications Alexa Geltzeiler
Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA
2 shared publications- Chalinee Monsereenusorn
Division of Hematology‐Oncology Department of Pediatrics Phramongkutklao Hospital and Phramongkutklao College of Medicine Bangkok Thailand
2 shared publications Robert J. Fee
Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital, New York, NY
2 shared publications- Alexa Geltzeiler
Department of Pediatrics, Boston Children's Hospital, Boston, MA
1 shared publication
Latest Publications
- 27 March 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (6) , e70273
Bridging Gaps in Survivorship Care in LMICs: A Multicenter Study on Healthcare Providers’ Perceptions of Late Effects in Pediatric Cancer in Thailand
Purpose: In low‐ and middle‐income countries, including Thailand, pediatric cancer survivorship care is limited by resource constraints, lack of structured programs, and an overemphasis on recurrence surveillance. Understanding healthcare provider (HCP) perceptions is a key first step toward developing sustainable multidisciplinary survivorship guidelines. Methods: The Doctor Assessment in Late‐Effects Treatment (DALET) survey was used to assess HCPs’ perceptions of late‐effect care. The survey was distributed nationwide to physicians involved in childhood cancer care using a targeted dissemination strategy guided by local experts. Results: A total of 114 physicians from 37 centers participated, with only 3 centers (8.1%) having dedicated late‐effect clinics. Most respondents (69.3%) reported prior training in late‐effect care, and 81.6% provided post‐treatment follow‐up. Overall knowledge showed good alignment with the Children's Oncology Group Long‐Term Follow‐Up Guidelines (mean score, 71.7%), with prior training independently associated with higher alignment ( p = 0.034). Confidence in managing physical late effects was significantly associated with physician expertise ( p < 0.001), hospital type ( p = 0.036), and prior training ( p < 0.001), while access to consultation varied by expertise and hospital type. Main barriers to late‐effect clinics were a lack of one‐stop multidisciplinary services (80.7%) and time constraints (78.9%). Conclusions: Gaps in training and confidence persist across specialties and institutions, highlighting the need for national policies that strengthen education, capacity building, multidisciplinary collaboration, and standardized guidelines to ensure equitable late‐effect care for pediatric cancer survivors in Thailand.
- 27 March 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (6) , e70273
Bridging Gaps in Survivorship Care in LMICs: A Multicenter Study on Healthcare Providers’ Perceptions of Late Effects in Pediatric Cancer in Thailand
Purpose: In low‐ and middle‐income countries, including Thailand, pediatric cancer survivorship care is limited by resource constraints, lack of structured programs, and an overemphasis on recurrence surveillance. Understanding healthcare provider (HCP) perceptions is a key first step toward developing sustainable multidisciplinary survivorship guidelines. Methods: The Doctor Assessment in Late‐Effects Treatment (DALET) survey was used to assess HCPs’ perceptions of late‐effect care. The survey was distributed nationwide to physicians involved in childhood cancer care using a targeted dissemination strategy guided by local experts. Results: A total of 114 physicians from 37 centers participated, with only 3 centers (8.1%) having dedicated late‐effect clinics. Most respondents (69.3%) reported prior training in late‐effect care, and 81.6% provided post‐treatment follow‐up. Overall knowledge showed good alignment with the Children's Oncology Group Long‐Term Follow‐Up Guidelines (mean score, 71.7%), with prior training independently associated with higher alignment ( p = 0.034). Confidence in managing physical late effects was significantly associated with physician expertise ( p < 0.001), hospital type ( p = 0.036), and prior training ( p < 0.001), while access to consultation varied by expertise and hospital type. Main barriers to late‐effect clinics were a lack of one‐stop multidisciplinary services (80.7%) and time constraints (78.9%). Conclusions: Gaps in training and confidence persist across specialties and institutions, highlighting the need for national policies that strengthen education, capacity building, multidisciplinary collaboration, and standardized guidelines to ensure equitable late‐effect care for pediatric cancer survivors in Thailand.
- Open Access
- 20 August 2024
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 531
Health-related quality of life and its determinant factors in Thai children with cancer: parents vs. children perspectives
Background Health-related quality of life (HRQOL) is a vital assessment to demonstrate the achievement in pediatric cancer care parallels that of medical treatment. The Pediatric Quality of Life Inventory (PedsQL) 3.0 Cancer Module in the Thai Version has become a standard tool to access the HRQOL among Thai children with cancer and their families. This study aimed to explore the HRQOL and factors related to HRQOL among pediatric oncology patients using the PedsQL 3.0 Cancer Module. Methods In 2018-2019, a single-institution, cross-sectional study was conducted among children with cancer and their families in Bangkok, Thailand. A paired-sample t-test was performed to evaluate the differences between the HRQOL scores of the child and parents' reports. Linear regression was used to evaluate factors associated with HRQOL and which particular domains of the PedsQL 3.0 Cancer Module were influenced. Results Eighty-five children with cancer and their families were enrolled. The patients' mean age was 10.82 +/- 5.48 years. The most common cancer types included acute lymphoblastic leukemia (n = 32, 67%), central nervous system tumors (n = 13, 15%), osteosarcoma (n = 10, 27%) and neuroblastoma (n = 9, 24%), in rank. The mean HRQOL scores in child and parent reports were 74.37 +/- 15.7 and 70.42 +/- 17.15, respectively (p = 0.034). Factors negatively correlated to HRQOL in parent reports were the number of outpatient visits (p = 0.019) and hospital admissions (p = 0.002). The number of hospitalizations was the only independent factor that affected HRQOL (p = 0.044). The number of outpatient visits and/or hospital admissions was influenced by pain and hurt, nausea, procedural anxiety and communication domains (p < 0.05). Only the number of hospitalizations was an independent factor influencing the procedural anxiety domain in HRQOL (p = 0.005). Conclusion HRQOL among Thai children with cancer was desirable from both children's and parent's perspectives. Differences between child and parent HRQOL scores were observed. The number of outpatient visits and hospital admissions affected HRQOL, particularly in the procedural anxiety aspect. Trial registration Thai Clinical Trials Registry (TCTR) Number: TCTR20200904001 (04/09/2020), https://www.thaiclinicaltrials.org/.
- 20 August 2024
- Published by Springer Nature in BMC Pediatrics
- Vol. 24 (1) , 531
Open AccessHealth-related quality of life and its determinant factors in Thai children with cancer: parents vs. children perspectives
Background Health-related quality of life (HRQOL) is a vital assessment to demonstrate the achievement in pediatric cancer care parallels that of medical treatment. The Pediatric Quality of Life Inventory (PedsQL) 3.0 Cancer Module in the Thai Version has become a standard tool to access the HRQOL among Thai children with cancer and their families. This study aimed to explore the HRQOL and factors related to HRQOL among pediatric oncology patients using the PedsQL 3.0 Cancer Module. Methods In 2018-2019, a single-institution, cross-sectional study was conducted among children with cancer and their families in Bangkok, Thailand. A paired-sample t-test was performed to evaluate the differences between the HRQOL scores of the child and parents' reports. Linear regression was used to evaluate factors associated with HRQOL and which particular domains of the PedsQL 3.0 Cancer Module were influenced. Results Eighty-five children with cancer and their families were enrolled. The patients' mean age was 10.82 +/- 5.48 years. The most common cancer types included acute lymphoblastic leukemia (n = 32, 67%), central nervous system tumors (n = 13, 15%), osteosarcoma (n = 10, 27%) and neuroblastoma (n = 9, 24%), in rank. The mean HRQOL scores in child and parent reports were 74.37 +/- 15.7 and 70.42 +/- 17.15, respectively (p = 0.034). Factors negatively correlated to HRQOL in parent reports were the number of outpatient visits (p = 0.019) and hospital admissions (p = 0.002). The number of hospitalizations was the only independent factor that affected HRQOL (p = 0.044). The number of outpatient visits and/or hospital admissions was influenced by pain and hurt, nausea, procedural anxiety and communication domains (p < 0.05). Only the number of hospitalizations was an independent factor influencing the procedural anxiety domain in HRQOL (p = 0.005). Conclusion HRQOL among Thai children with cancer was desirable from both children's and parent's perspectives. Differences between child and parent HRQOL scores were observed. The number of outpatient visits and hospital admissions affected HRQOL, particularly in the procedural anxiety aspect. Trial registration Thai Clinical Trials Registry (TCTR) Number: TCTR20200904001 (04/09/2020), https://www.thaiclinicaltrials.org/.
- Open Access
Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder
Purpose: Pathogenic variants in Kinesin Family Member 1A ( KIF1A ) are associated with KIF1A -associated neurological disorder (KAND). We report the clinical phenotypes and correlate genotypes of individuals with KAND. Methods: Medical history and adaptive function were assessed longitudinally. In-person evaluations included neurological, motor, ophthalmologic and cognitive assessments. Results: We collected online data on 177 individuals. Fifty-seven individuals were also assessed in-person. Most individuals had de novo heterozygous missense likely pathogenic/pathogenic KIF1A variants. The most common characteristics were hypotonia, spasticity, ataxia, seizures, optic nerve atrophy, cerebellar atrophy, and cognitive impairment. Mean Vineland Adaptive Behavior Composite score (VABS-ABC) was low ( M =62.9, SD =19.1). The mean change in VABS-ABC over time was -3.1 ( SD =7.3). The decline in VABS-ABC was associated with the age at first assessment and abnormal electroencephalogram/seizure. There was a positive correlation between Evolutionary Scale Model (ESM) score for the variants and final VABS-ABC ( p =0.003). Abnormal electroencephalogram/seizure, neuroimaging result, and ESM explain 34% of the variance in final VABS-ABC ( p <0.001). Conclusion: In-person assessment confirmed caregiver report and identified additional visual deficits. Adaptive function declined over time consistent with both the neurodevelopmental and neurodegenerative nature of the condition. Using ESM score assists in predicting phenotype across a wide range of unique variants.
Open AccessHeterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological disorder
Purpose: Pathogenic variants in Kinesin Family Member 1A ( KIF1A ) are associated with KIF1A -associated neurological disorder (KAND). We report the clinical phenotypes and correlate genotypes of individuals with KAND. Methods: Medical history and adaptive function were assessed longitudinally. In-person evaluations included neurological, motor, ophthalmologic and cognitive assessments. Results: We collected online data on 177 individuals. Fifty-seven individuals were also assessed in-person. Most individuals had de novo heterozygous missense likely pathogenic/pathogenic KIF1A variants. The most common characteristics were hypotonia, spasticity, ataxia, seizures, optic nerve atrophy, cerebellar atrophy, and cognitive impairment. Mean Vineland Adaptive Behavior Composite score (VABS-ABC) was low ( M =62.9, SD =19.1). The mean change in VABS-ABC over time was -3.1 ( SD =7.3). The decline in VABS-ABC was associated with the age at first assessment and abnormal electroencephalogram/seizure. There was a positive correlation between Evolutionary Scale Model (ESM) score for the variants and final VABS-ABC ( p =0.003). Abnormal electroencephalogram/seizure, neuroimaging result, and ESM explain 34% of the variance in final VABS-ABC ( p <0.001). Conclusion: In-person assessment confirmed caregiver report and identified additional visual deficits. Adaptive function declined over time consistent with both the neurodevelopmental and neurodegenerative nature of the condition. Using ESM score assists in predicting phenotype across a wide range of unique variants.
- 13 November 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (3) , e63471
Clinical phenotypes of individuals with Chung–Jansen syndrome across age groups
Pathogenic variants in pleckstrin homology domain interacting protein (PHIP) are associated with Chung–Jansen syndrome characterized by developmental delay, intellectual disability, behavioral challenges, hypotonia, obesity, and dysmorphic features. We report phenotypes and genotypes of 47 individuals with likely pathogenic/pathogenic PHIP variants. Variants were de novo in 61.7%, unknown inheritance in 29.8%, and inherited in 8.5%. The median age of the individuals was 10.9 years, approximately equally divided by sex. Individuals in this cohort frequently had a history of developmental delay (85.1%), attention‐deficit/hyperactivity disorder (51.1%), anxiety (46.8%), depression (27.7%), and sleep difficulties (42.6%). Depression was significantly higher in the older age group (>12 years old). Most individuals had moderately low adaptive functioning based on the Vineland‐3 (mean = 76.8, standard deviation = 12.0). Overall, 55.8% of individuals were obese/overweight. The percentage of obese individuals was greater in the older age group (>12 years old) and evolves over time. Other common symptoms were hypotonia (78.7%), constipation (48.9%), visual problems (66%), and cryptorchidism (39.1% of males). Our findings provide additional natural history data for Chung–Jansen syndrome and provide opportunities for early intervention of healthy eating habits and awareness of developing mood and behavioral challenges over the life course.
- 13 November 2023
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 194 (3) , e63471
Clinical phenotypes of individuals with Chung–Jansen syndrome across age groups
Pathogenic variants in pleckstrin homology domain interacting protein (PHIP) are associated with Chung–Jansen syndrome characterized by developmental delay, intellectual disability, behavioral challenges, hypotonia, obesity, and dysmorphic features. We report phenotypes and genotypes of 47 individuals with likely pathogenic/pathogenic PHIP variants. Variants were de novo in 61.7%, unknown inheritance in 29.8%, and inherited in 8.5%. The median age of the individuals was 10.9 years, approximately equally divided by sex. Individuals in this cohort frequently had a history of developmental delay (85.1%), attention‐deficit/hyperactivity disorder (51.1%), anxiety (46.8%), depression (27.7%), and sleep difficulties (42.6%). Depression was significantly higher in the older age group (>12 years old). Most individuals had moderately low adaptive functioning based on the Vineland‐3 (mean = 76.8, standard deviation = 12.0). Overall, 55.8% of individuals were obese/overweight. The percentage of obese individuals was greater in the older age group (>12 years old) and evolves over time. Other common symptoms were hypotonia (78.7%), constipation (48.9%), visual problems (66%), and cryptorchidism (39.1% of males). Our findings provide additional natural history data for Chung–Jansen syndrome and provide opportunities for early intervention of healthy eating habits and awareness of developing mood and behavioral challenges over the life course.